MedWatch

Leo director: New recommendation is an important first step

Leo Pharma has won a positive CHMP-recommendation of the biological drug brodalumab – an important milestone in the company’s gamble on biologics “This shows that we take the biological field seriously,” says its R&D chief.

Denmark's Leo Pharma has successfully completed the first step in its new venture into the field for biological medicine.

The European Medicines Agency’s advisory committee CHMP has recommended approval of the first of the two drugs Leo Pharma bought from AstraZeneca last year.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier